Sedating ventilated COVID-19 patients with inhalational anesthetic drugs
- PMID: 32344199
- PMCID: PMC7172604
- DOI: 10.1016/j.ebiom.2020.102770
Sedating ventilated COVID-19 patients with inhalational anesthetic drugs
Conflict of interest statement
Declaration of Competing Interest B.A.O. is an inventor named on a Canadian patent (2852978), a US patent (9517265), and a pending US patent (62/268,137). D.S.W. and W.Y.L have no competing interests.
Comment on
-
Sevoflurane for Sedation in Acute Respiratory Distress Syndrome. A Randomized Controlled Pilot Study.Am J Respir Crit Care Med. 2017 Mar 15;195(6):792-800. doi: 10.1164/rccm.201604-0686OC. Am J Respir Crit Care Med. 2017. PMID: 27611637 Clinical Trial.
References
-
- Jabaudon M., Boucher P., Imhoff E., Chabanne R., Faure J.S., Roszyk L. Sevoflurane for sedation in acute respiratory distress syndrome. A randomized controlled pilot study. Am J Respir Crit Care Med. 2017;195:792–800. - PubMed
-
- Jerath A., Parotto M., Wasowicz M., Ferguson N.D. Volatile anesthetics. Is a new player emerging in critical care sedation? Am J Respir Crit Care Med. 2016;193:1202–1212. - PubMed
-
- American Society of Anesthesiologists, Anesthesia Patient Safety Foundation. APSF/ASA guidance on purposing anesthesia machines as ICU ventilators. https://wwwasahqorg/in-the-spotlight/coronavirus-covid-19-information/pu... (Accessed April 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources